Self-Monitoring Blood Glucose (SMBG) device market is primary dependent on diabetes population. In 2015, as per International Diabetes Federation, one in 11 adults has been suffering from diabetes and this trend is forecasted to increase to one in 10 adults by 2040. It shows that diabetes prevalence is continuously growing which help to boost the SMBG device market globally. Our research report “Blood Glucose Device Market & Forecast (SMBG) (Test Strips, Lancet, Meter) – Worldwide Analysis” provide details on following points:
15 Countries Covered Blood Glucose Device Market & Patient Numbers Covered
Increasing Diabetes Population Worldwide
World leaders, politicians and policy leaders can no longer afford to ignore the evidence of diabetes. Peoples are suffering from diabetes from communities in the Northern Territories of Australia to the manic streets of India Mumbai as well as the wealthy avenues of USA Manhattan and around the world in metropolitan cities and rural community in sub-Saharan Africa where diabetes is drastically on the growth. Almost half of the total diabetes population is not aware they have it and nearly 75 percent of all people with diagnosed and undiagnosed diabetes live in low- and middle-income countries. Worldwide diabetes population is expected to increase to 642 Million by 2040, from 415 Million in 2015.
Test Strips Market Dominating Worldwide Blood Glucose Device Market (SMBG)
SMBG device is the combination of blood glucose meter, blood glucose test strips and lancet devices. For performing the self-monitoring of blood glucose, users need all three devices at once. Blood glucose lancet is used for the skin to obtain a drop of a blood sample that is then placed on a disposable blood glucose test strip which is inserted into a blood glucose meter to calculate the glucose level in the blood.
Self-Monitoring Blood Glucose (SMBG) Device Market is Mainly Dominated by Developed Countries
SMBG device market is mainly dominated by developed countries such as United States, Russia and United Kingdom. These three together hold more than 60 percent of the Global SMBG market share. High per capita spending, affordable healthcare infrastructure, growing awareness about diabetes, government diabetes control policy, government insurance policy and reimbursement plan playing the major role to lead the developed countries in this marketplace.
Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.
Follow us on LinkedIn: http://www.linkedin.com/company/renub-research